ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
117 hedge funds and large institutions have $476M invested in Intra-Cellular Therapies Inc. in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 38 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
11% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 38
32% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 22
Holders
117
Holding in Top 10
1
Calls
$4.41M
Puts
$2.9M
Top Buyers
| 1 | +$57.9M | |
| 2 | +$8.92M | |
| 3 | +$6.92M | |
| 4 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$5.69M |
| 5 |
SC
Samlyn Capital
New York
|
+$5.5M |
Top Sellers
| 1 | -$23.2M | |
| 2 | -$15.5M | |
| 3 | -$7.52M | |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$4.74M |
| 5 |
CCI
Columbus Circle Investors
|
-$2.25M |